2. Search Result
Search Result
Results for "

PKMYT1

" in MedChemExpress (MCE) Product Catalog:

17

Inhibitors & Agonists

2

Recombinant Proteins

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145817A
    lunresertib
    1 Publications Verification

    RP-6306

    		 Wee1 Cancer
    lunresertib (RP-6306) is a potent, selective and orally active PKMYT1 inhibitor with an IC50 of 14 nM. lunresertib shows a high degree of selectivity over other kinases in cellular binding assays. lunresertib shows anticancer effects [1].
    lunresertib
  • HY-145666
    Myt1-IN-3

    		Wee1 Cancer
    Myt1-IN-3 is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50s of <10 nM (WO2021195782 A1, compound 95) [1].
    Myt1-IN-3
  • HY-RS10605
    PKMYT1 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    PKMYT1 Human Pre-designed siRNA Set A contains three designed siRNAs for PKMYT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    PKMYT1 Human Pre-designed siRNA Set A
    PKMYT1 Human Pre-designed siRNA Set A
  • HY-162849
    PKMYT1-IN-3

    		Wee1 Cancer
    PKMYT1-IN-3 (compound 8ma) is a potent and selective PKMYT1 inhibitor with an IC50 value of 16.5 nM. PKMYT1-IN-3 has antitumor activity [1].
    PKMYT1-IN-3
  • HY-163491
    PKMYT1-IN-2

    		Wee1 Cancer
    PKMYT1-IN-2 (compound 2) is a potent PKMYT1 inhibitor with an IC50 of 5.7 nM. PKMYT1-IN-2 inhibits the growth of HCC1569 cells with an IC50 of 22 nM [1].
    PKMYT1-IN-2
  • HY-162987
    PKMYT1-IN-6

    		Wee1 Cancer
    PKMYT1-IN-6 (compund 98) is a PKMYT1 inhibitor with IC50 less than 50 nM [1].
    PKMYT1-IN-6
  • HY-162986
    PKMYT1-IN-4

    		Wee1 Cancer
    PKMYT1-IN-4 (compund 27) is a PKMYT1 inhibitor with IC50 less than 50 nM [1].
    PKMYT1-IN-4
  • HY-163490
    PKMYT1-IN-1

    		Wee1 Cancer
    PKMYT1-IN-1 (Compound 1) is an inhibitor for membrane-associated tyrosine and threonine kinase (PKMYT1), with an IC50 of 8.8 nM. PKMYT1-IN-1 inhibits proliferation of tumor cell HCC1569 with IC50 of 42 nM [1].
    PKMYT1-IN-1
  • HY-170517
    PKMYT1-IN-8

    		Wee1 Ephrin Receptor Cancer
    PKMYT1-IN-8 (Compound 137) is the inhibitor for PKMYT1 with an IC50 of 9 nM. PKMYT1-IN-8 inhibits EPHB3, EPHA1, KIT, EPHB1, EPHA2, EPHA3, and EPHB2with IC50s of 1.79, 3.17, 4.29, 6.32, 6.83, 8.10, and 10.9 μM, respectively. PKMYT1-IN-8 inhibits the proliferation of cancer cell OVCAR3 with GI50 of 2.02 μM [1].
    PKMYT1-IN-8
  • HY-169946
    WEE1/PKMYT1-IN-1

    		Wee1 Cancer
    WEE1/PKMYT1-IN-1 (compound 75) is a potent and orally active WEE1 and PKMYT1 inhibitor. WEE1/PKMYT1-IN-1 shows antiproliferation activity [1].
    WEE1/PKMYT1-IN-1
  • HY-147312
    GSK-1520489A

    		Wee1 Cancer
    GSK-1520489A is a PKMYT1 (active protein kinase) inhibitor (IC50=115 nM, Ki=10.94 nM) [1].
    GSK-1520489A
  • HY-162988
    Myt1-IN-5

    		Wee1 Cancer
    Myt1-IN-5 (compound 4) is a membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of less than 200 nM.
    Myt1-IN-5
  • HY-145817
    (Rac)-lunresertib

    (Rac)-RP-6306

    		 Wee1 Cancer
    (Rac)-lunresertib (compound 181) is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of <10 nM. (Rac)-lunresertib (compound 181) has anticancer effects [1].
    (Rac)-lunresertib
  • HY-145817B
    (R)-lunresertib

    (R)-RP-6306

    		 Wee1 Cancer
    (R)-lunresertib is a membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor, with IC50 of 1360 nM. (R)-lunresertib can be used in the study of Myt1-mediated cancers [1].
    (R)-lunresertib
  • HY-145664
    Myt1-IN-1

    		Wee1 Cancer
    Myt1-IN-1 is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of <10 nM. Myt1-IN-1 has anticancer effects (WO2021195782A1; compound 132) [1].
    Myt1-IN-1
  • HY-145665
    Myt1-IN-2

    		Wee1 Cancer
    Myt1-IN-2 is a potent membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor with an IC50 of <10 nM. Myt1-IN-2 has anticancer effects (WO2021195782A1; compound 28) [1].
    Myt1-IN-2
  • HY-157443
    Myt1-IN-4

    		Wee1 Cancer
    Myt1-IN-4 (21) is an orally active and selective membrane-associated tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1) (Gene name PKMYT1) inhibitor, with an IC50 of 2.6 nM. Myt1-IN-4 (21) possesses antitumor activity [1].
    Myt1-IN-4

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: